Skip to main content

Table 5 Annual deaths, PHN3 a incidence and QALYb loss due to Herpes Zoster (HZ) in Germanyc, 2007/2008

From: Herpes zoster in Germany: Quantifying the burden of disease

  Deaths PHN incidence based on different szenariosd QALY loss due to HZ
  Min Max   
age group (years) Deaths mortality ratee CI (95%) Incidencef CI (95%) Incidencef CI (95%) Ming Maxg
50 - 54 1 0.02 0.00 - 0.10 0.05 0.04 - 0.06 0.50 0.48 - 0.52 362 942
55 - 59 0 0.00 NA 0.22 0.21 - 0.23 0.76 0.74 - 0.78 403 1,047
60 - 64 1 0.02 0.00 - 0.13 0.26 0.24 - 0.28 0.98 0.95 - 1.01 378 2,531
65 - 69 3 0.06 0.01 - 0.17 0.35 0.34 - 0.37 1.39 1.36 - 1.42 558 3,740
70 - 74 5 0.11 0.04 - 0.27 0.37 0.36 - 0.39 1.70 1.66 - 1.74 495 5,442
75 - 79 9 0.30 0.14 - 0.57 0.78 0.75 - 0.81 2.19 2.14 - 2.24 366 4,030
80 - 84 12 0.54 0.28 - 0.94 0.96 0.92 - 1.01 2.63 2.56 - 2.70 278 5,562
85 - 89 15 1.20 0.67 - 1.98 0.97 0.92- 1.03 2.39 2.31 - 2.48 157 3,137
90+ 20 3.86 2.36 - 5.96 1.02 0.93 - 1.11 2.51 2.37 - 2.65 68 1,366
total 66 0.21 0.16 - 0.26 0.43 0.43 - 0.44 1.33 1.32 - 1.34 3,065 24,094
  1. CI = confidence interval; NA = not applicable
  2. apostherpetic neuralgia lasting over three months after HZ diagnosis.
  3. bquality-adjusted life year.
  4. cextrapolation on living population in Germany based on study sample
  5. ddata based on Schiffner-Rohe et al. 2010 [28], Gauthier et al. 2009 [25], Opstelten et al. 2002 [27].
  6. edeaths per 100,000 person-years.
  7. fcases per 1,000 person-years.
  8. gdata based on van Hoek et al. 2009 [29], Brisson et al. 2008 [24], Edmunds et al. 2001 [31].